Activating Transcription Factor 3 (ATF3) (C-Term) Peptide
ATF3
Reactivity: Human, Mouse
Host: Synthetic
BP, WB
-
- Target See all ATF3 products
- ATF3 (Activating Transcription Factor 3 (ATF3))
- Protein Region
- C-Term
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- ESVNAELKAQ IEELKNEKQH LIYMLNLHRP TCIVRAQNGR TPEDERNLFI
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Atf3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ATF3 (Activating Transcription Factor 3 (ATF3))
- Synonyms
- zgc:55526 Peptide, ATF3 Peptide, LRG-21 Peptide, LRF-1 Peptide, LRFI Peptide, atf-3 Peptide, activating transcription factor 3 Peptide, activating transcription factor 3 L homeolog Peptide, atf3 Peptide, ATF3 Peptide, Atf3 Peptide, atf3.L Peptide
- Background
-
This protein binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters. Represses transcription from promoters with ATF sites. It may repress transcription by stabilizing the binding of inhibitory cofactors at the promoter.
Alias Symbols: LRG-21
Protein Size: 181 - Molecular Weight
- 21 kDa
- Gene ID
- 11910
- NCBI Accession
- NM_007498, NP_031524
- UniProt
- Q60765
-
You are here:
